Veloxis Pharmaceuticals A/S (OMX: VELO), today announced that Envarsus ® XR was granted Orphan Drug status by the U.S. Food and Drug Administration (FDA) for prophylaxis of organ rejection in patients ...

Please provide your email address to receive an email when new articles are posted on . The U.S. Food and Drug Administration has approved Envarsus XR (tacrolimus extended-release tablets) to prevent ...

Veloxis Pharmaceuticals A/S (OMX: VELO) today announced U.S. Food and Drug Administration (FDA) approval of Envarsus ® XR (tacrolimus extended-release tablets) for the prophylaxis of rejection in ...

Find clinical guidance on Envarsus XR, including indications, dosing, safety, side effects and evidence-based insights for healthcare professionals.

In the study, Envarsus XR proved non-inferior to immediate-release tacrolimus as seen by treatment failure rates. Veloxis announced the submission of a supplemental New Drug Application (sNDA) to the ...

Veloxis Pharmaceuticals A/S has announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for the marketing and sale of Envarsus® ...

Veloxis Pharmaceuticals, Inc. (Veloxis), a global specialty pharmaceutical company part of Asahi Kasei Corporation, which is committed to improving the lives of transplant and other immunocompromised ...

COPENHAGEN, Denmark, June 6, 2017 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that its US subsidiary, Veloxis Pharmaceuticals, Inc., has entered into an exclusive license, ...

Veloxis Pharmaceuticals A/S’ board chairman, Michael Heffernan, said investors will find out in “the next four weeks” more details related to the $1.3 billion takeover by Tokyo-based Asahi Kasei Corp.

The Texas Attorney General announced an investigation into StubHub Inc on Friday, amid dozens of complaints that World Cup tickets purchased on the resale platform were never delivered. Reuters, the ...

COPENHAGEN, Denmark and DUBLIN, June 6, 2017 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that its U.S. subsidiary, Veloxis Pharmaceuticals, Inc., and Endo Ventures Limited ...

Tacrolimus 0.75mg, 1mg, 4mg; ext-rel tabs. Tacrolimus binds to an intracellular protein, FKBP-12. A complex of tacrolimus-FKBP-12, calcium, calmodulin, and calcineurin (an ubiquitous mammalian ...